An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

Beloved Australian actor, Magda Szubanski, has revealed she’s been diagnosed with a “very rare, very aggressive, very serious ...

Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge cancer care closer to patients in ...

Discover 3 major herpes triggers you can eliminate today. Learn proven prevention strategies to reduce outbreaks and regain ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

Is it better to take B6 vs. B12? A dietitian explains that both are necessary for supporting your overall health, but there ...

Victoria's Royal Jubilee adopts bispecific T-cell engagers, which show great promise, according to Island Health ...

Exposure to the sun's light can be both beneficial and harmful. New research has suggested new uses for light therapy beyond ...

KPV peptide, a small bioactive tripeptide, has garnered increasing attention within various research domains due to its ...